Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Medtronic recalled its infusion sets — or disposable devices used to connect insulin pumps to the body — over malfunction issues, reports Bloomberg.
Teva Pharmaceuticals on Monday named Lundbeck's Kare Schultz its new CEO, reports Reuters.
Lupin Pharmaceuticals earned Food and Drug Administration approval for its generic doxycycline hyclate tablets, reports Business Standard.
Here are seven drugmakers that made headlines in the past week.
Meridian Medical Technologies, a Pfizer subsidiary that manufacturers EpiPen's for Mylan, is in hot water for failing to adequately investigate complaints about the auto-injectors' efficacy, according to The Washington Post.
Genentech on Wednesday recalled its clot-busting drug Activase due to sterility issues.
An ad sales team at Facebook hosted a breakfast for select pharmaceutical marketers Thursday to discuss how to target its users for clinical trials, reports CNBC.
While innovative strategies, actionable plans, and informed decision-making are all critical components for an effective supply chain, the strongest leaders must also know how to react in the face of adversity.
Scott Nelson, Senior Vice President of Supply Chain at Cardinal Health
CMS on Thursday issued new guidance to help beneficiaries replace medical equipment and supplies that were lost or damaged from Hurricane Harvey.
Here are seven articles published by Becker's Hospital Review in the last week, which highlight six regulatory decisions to watch for in September, Hospira's recall of two drugs and a supply chain tip for seasonal demand planning, among other topics.